Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0138 | 0.0908 | 0.4837 |
Loa Loa (eye worm) | CAMK/PIM protein kinase | 0.0155 | 0.1101 | 0.5863 |
Brugia malayi | MH2 domain containing protein | 0.0138 | 0.0908 | 0.4781 |
Leishmania major | protein kinase, putative | 0.006 | 0.002 | 0.5 |
Brugia malayi | Stress-activated protein kinase jnk-1 | 0.0224 | 0.1877 | 1 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.0942 | 1 | 0.5 |
Trypanosoma cruzi | kinetoplastid kinetochore protein 10, putative | 0.006 | 0.002 | 0.5 |
Leishmania major | protein kinase, putative | 0.006 | 0.002 | 0.5 |
Echinococcus multilocularis | c Jun NH2 terminal kinase | 0.0224 | 0.1877 | 1 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0942 | 1 | 0.5 |
Echinococcus multilocularis | proto oncogene serine:threonine protein kinase | 0.0155 | 0.1101 | 0.5863 |
Echinococcus multilocularis | dual specificity protein kinase clk2 | 0.006 | 0.002 | 0.0107 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0224 | 0.1877 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0138 | 0.0908 | 0.4837 |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.0942 | 1 | 1 |
Loa Loa (eye worm) | CAMK/CAMKL/CHK1 protein kinase | 0.0163 | 0.1187 | 0.6326 |
Echinococcus granulosus | c-Jun N-terminal kinases | 0.0224 | 0.1877 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0122 | 0.0728 | 0.5 |
Trypanosoma cruzi | kinetoplastid kinetochore protein 19, putative | 0.006 | 0.002 | 0.5 |
Echinococcus granulosus | dual specificity protein kinase clk2 | 0.006 | 0.002 | 0.0107 |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.0942 | 1 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.006 | 0.002 | 0.5 |
Trypanosoma brucei | kinetoplastid kinetochore protein 19 | 0.006 | 0.002 | 0.5 |
Trypanosoma brucei | kinetoplastid kinetochore protein 10 | 0.006 | 0.002 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0155 | 0.1101 | 0.5818 |
Loa Loa (eye worm) | CMGC/CLK protein kinase | 0.006 | 0.002 | 0.0107 |
Brugia malayi | Serine/threonine-protein kinase Pim-3 | 0.0155 | 0.1101 | 0.5818 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.0942 | 1 | 1 |
Trypanosoma cruzi | kinetoplastid kinetochore protein 10, putative | 0.006 | 0.002 | 0.5 |
Toxoplasma gondii | cell-cycle-associated protein kinase CLK, putative | 0.006 | 0.002 | 0.5 |
Trypanosoma cruzi | kinetoplastid kinetochore protein 19, putative | 0.006 | 0.002 | 0.5 |
Onchocerca volvulus | Serine\/threonine protein kinase homolog | 0.0155 | 0.1101 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0122 | 0.0728 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0122 | 0.0728 | 0.5 |
Loa Loa (eye worm) | CMGC/MAPK/JNK protein kinase | 0.0224 | 0.1877 | 1 |
Brugia malayi | Protein kinase domain containing protein | 0.0155 | 0.1101 | 0.5818 |
Brugia malayi | Protein kinase domain containing protein | 0.0163 | 0.1187 | 0.6286 |
Loa Loa (eye worm) | CAMK/PIM protein kinase | 0.0155 | 0.1101 | 0.5863 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0122 | 0.0728 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0122 | 0.0728 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.0942 | 1 | 0.5 |
Giardia lamblia | Kinase, CMGC CLK | 0.006 | 0.002 | 0.5 |
Echinococcus granulosus | proto oncogene serine:threonine protein kinase | 0.0155 | 0.1101 | 0.5863 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0163 | 0.1187 | 0.6286 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0942 | 1 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.